Molini, U.; Coetzee, L.M.; Engelbrecht, T.; de Villiers, L.; de Villiers, M.; Mangone, I.; Curini, V.; Khaiseb, S.; Ancora, M.; Cammà , C.;
et al. SARS-CoV-2 in Namibian Dogs. Vaccines 2022, 10, 2134.
https://doi.org/10.3390/vaccines10122134
AMA Style
Molini U, Coetzee LM, Engelbrecht T, de Villiers L, de Villiers M, Mangone I, Curini V, Khaiseb S, Ancora M, Cammà C,
et al. SARS-CoV-2 in Namibian Dogs. Vaccines. 2022; 10(12):2134.
https://doi.org/10.3390/vaccines10122134
Chicago/Turabian Style
Molini, Umberto, Lauren M. Coetzee, Tanya Engelbrecht, Lourens de Villiers, Mari de Villiers, Iolanda Mangone, Valentina Curini, Siegfried Khaiseb, Massimo Ancora, Cesare Cammà ,
and et al. 2022. "SARS-CoV-2 in Namibian Dogs" Vaccines 10, no. 12: 2134.
https://doi.org/10.3390/vaccines10122134
APA Style
Molini, U., Coetzee, L. M., Engelbrecht, T., de Villiers, L., de Villiers, M., Mangone, I., Curini, V., Khaiseb, S., Ancora, M., Cammà , C., Lorusso, A., & Franzo, G.
(2022). SARS-CoV-2 in Namibian Dogs. Vaccines, 10(12), 2134.
https://doi.org/10.3390/vaccines10122134